Your session is about to expire
← Back to Search
SMART Program for Inflammatory Bowel Disease
N/A
Waitlist Available
Led By Victor G. Chedid, M.D., M.S.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, approximately 20 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial looks at how a SMART Program can improve the quality of life & reduce healthcare use for those with IBD.
Who is the study for?
This trial is for individuals with inflammatory bowel disease (IBD) who feel stress affects their symptoms. Participants must have internet access and a device like a smartphone, tablet, or computer. They can't join if they've used corticosteroids in the past 3 months or use illicit substances including medical marijuana.
What is being tested?
The study examines how a Stress Management and Resilience Training (SMART) Program might improve life quality and affect healthcare needs for those with IBD. It's about learning to handle stress better to see if it helps manage IBD symptoms.
What are the potential side effects?
Since this program focuses on managing stress rather than medication, there are no direct side effects like you'd expect from drugs. However, participants may experience varying levels of emotional discomfort when addressing personal stressors.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, approximately 20 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, approximately 20 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Inflammatory Bowel Disease (IBD) Quality of Life (QOL)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Stress management and resilience trainingExperimental Treatment1 Intervention
Subjects will receive a 1.5 hour one-on-one stress management and resilience consult by a certified SMART trainer followed by 16 week self-guided on-line training.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Stress Management and Resilience Training Program
2018
N/A
~40
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,362 Previous Clinical Trials
3,066,107 Total Patients Enrolled
Victor G. Chedid, M.D., M.S.Principal InvestigatorMayo Clinic
Shayla Schoenoff, PA-C, MSPrincipal InvestigatorMayo Clinic